– Pioneering a New Era Where Global Patients
Can Embrace Beauty and Confidence Through Japan's Cutting-Edge
Medical Aesthetics –
Shonan Beauty Clinic, supported by SBC Medical Group Holdings
Incorporated (Nasdaq: SBC) (“SBC Medical,” or the “Company”) in
management services, today announced the launch of its proprietary
translation app tailored for medical aesthetics staff and the
full-scale implementation of its "Inbound-Focused Clinics"
initiative. This groundbreaking move is designed to address the
growing demand for medical tourism and ensure that international
patients can seamlessly experience Japan's advanced medical
aesthetic treatments.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20250120588355/en/
Shonan Beauty Clinic, supported by SBC
Medical Group Holdings Incorporated (Nasdaq: SBC) in management
services, today announced the launch of its proprietary translation
app tailored for medical aesthetics staff and the full-scale
implementation of its "Inbound-Focused Clinics" initiative. This
groundbreaking move is designed to address the growing demand for
medical tourism and ensure that international patients can
seamlessly experience Japan's advanced medical aesthetic
treatments. (Photo: Business Wire)
Capitalizing on Medical Tourism’s Expanding
Opportunities
The global medical aesthetics market is projected to grow at a
compound annual growth rate (CAGR) of 12.17% from 2024, reaching
$212.5 billion by 2032. Within Asia, rising awareness of aesthetic
care and the increasing appeal of medical tourism are positioning
countries like Japan, South Korea, and Thailand as top destinations
for international patients. In Japan, the influx of foreign
patients seeking high-quality medical aesthetics continues to rise.
SBC alone welcomes over 10,000 inbound patients annually, with
inquiries surpassing 20,000 each year. China remains a key market
driver, though demand from English-speaking regions is also on the
rise. Recognizing this trend, SBC is scaling up its operational
capacity and implementing innovative solutions to support
sustainable growth in this dynamic sector.
Revolutionizing Communication with a Specialized Translation
App
To address language barriers, SBC has developed a
state-of-the-art translation app tailored specifically for medical
aesthetics. This app ensures the accurate translation of
specialized terminology, facilitating seamless communication
between clinic staff and international patients. Currently
supporting English and Chinese, the app plays a pivotal role in
enabling smooth consultations and pre-treatment explanations. By
creating a welcoming environment where language is no obstacle, SBC
empowers patients to feel secure and confident in their treatment
choices. Future plans include expanding the app's language
capabilities and rolling it out across all clinics nationwide,
ensuring comprehensive accessibility for a global clientele.
"Inbound-Focused Clinics" to Drive Regional
Development
SBC has designated three flagship locations – Shinjuku Main
Clinic, Shinbashi-Ginza Clinic, and Osaka Umeda Clinic – as
"Inbound-Focused Clinics." These facilities are staffed with
dedicated English- and Chinese-speaking concierges, ensuring
seamless, trustworthy communication. To further enhance
accessibility, SBC plans to extend this initiative to key cities
including Yokohama, Nagoya, Sendai, and Sapporo. With these
measures in place, the company aims to double its annual inbound
patient volume to 20,000 by this year.
A Vision for the Future: Medical Tourism as a "Beauty
Infrastructure"
SBC’s mission transcends the delivery of aesthetic treatments.
It strives to offer patients an unparalleled experience of "beauty"
and "confidence" – values deeply rooted in Japan’s culture and
technological excellence. By combining state-of-the-art medical
aesthetics with the renowned warmth of Japanese hospitality, SBC is
setting a new standard for tourism where healthcare, beauty, and
culture intersect. This initiative not only boosts inbound tourism
but also plays a vital role in regional revitalization and the
broader growth of Japan’s medical tourism sector. Through its
commitment to "delivering beauty beyond medicine," SBC continues to
redefine the global landscape of medical aesthetics and inspire
patients worldwide.
About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo,
Japan, owns and provides management services and products to
cosmetic treatment centers. The Company is primarily focused on
providing comprehensive management services to franchisee clinics,
including but not limited to advertising and marketing needs across
various platforms (such as social media networks), staff management
(such as recruitment and training), booking reservations for
franchisee clinic customers, assistance with franchisee employee
housing rentals and facility rentals, construction and design of
franchisee clinics, medical equipment and medical consumables
procurement (resale), the provision of cosmetic products to
franchisee clinics for resale to clinic customers, licensure of the
use of patent-pending and non-patented medical technologies,
trademark and brand use, IT software solutions (including but not
limited to remote medical consultations), management of the
franchisee clinic’s customer rewards program (customer loyalty
point program), and payment tools for the franchisee clinics.
For more information, visit https://sbc-holdings.com/
Forward-Looking Statements
This press release contains forward-looking statements.
Forward-looking statements are not historical facts or statements
of current conditions, but instead represent only the Company’s
beliefs regarding future events and performance, many of which, by
their nature, are inherently uncertain and outside of the Company’s
control. These forward-looking statements reflect the Company’s
current views with respect to, among other things, the Company’s
product launch plans and strategies; growth in revenue and
earnings; and business prospects. In some cases, forward-looking
statements can be identified by the use of words such as “may,”
“should,” “expects,” “anticipates,” “contemplates,” “estimates,”
“believes,” “plans,” “projected,” “predicts,” “potential,”
“targets” or “hopes” or the negative of these or similar terms. The
Company cautions readers not to place undue reliance upon any
forward-looking statements, which are current only as of the date
of this release and are subject to various risks, uncertainties,
assumptions, or changes in circumstances that are difficult to
predict or quantify. The forward-looking statements are based on
management’s current expectations and are not guarantees of future
performance. The Company does not undertake or accept any
obligation to release publicly any updates or revisions to any
forward-looking statements to reflect any change in its
expectations or any change in events, conditions, or circumstances
on which any such statement is based, except as required by law.
Factors that may cause actual results to differ materially from
current expectations may emerge from time to time, and it is not
possible for the Company to predict all of them; such factors
include, among other things, changes in global, regional, or local
economic, business, competitive, market and regulatory conditions,
and those listed under the heading “Risk Factors” and elsewhere in
the Company’s filings with the U.S. Securities and Exchange
Commission (the “SEC”), which are accessible on the SEC’s website
at www.sec.gov.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250120588355/en/
SBC Medical Group Holdings Incorporated Hikaru Fukui / Head of
Investor Relations e-mail: ir@sbc-holdings.com
SBC Medical (NASDAQ:SBC)
Historical Stock Chart
From Jan 2025 to Feb 2025
SBC Medical (NASDAQ:SBC)
Historical Stock Chart
From Feb 2024 to Feb 2025